Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis, Phase IIa Clinical Study
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2017
At a glance
- Drugs P 03277 (Primary)
- Indications Liver cirrhosis; Liver disorders
- Focus Diagnostic use; Proof of concept
- Sponsors Guerbet
- 28 Nov 2017 Planned End Date changed from 1 Aug 2017 to 1 Sep 2018.
- 28 Nov 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2018.
- 03 Jan 2017 Status changed from not yet recruiting to recruiting.